Login / Signup

Basal and Bolus Insulin Dose Changes after Switching Basal Insulin to Insulin Degludec in Patients with Type 1 Diabetes Mellitus: A Pilot Study.

Yoshiyuki HamamotoSachiko HonjoKanta FujimotoShinsuke TokumotoHiroki IkedaYoshiharu WadaHiroyuki Koshiyama
Published in: Clinical drug investigation (2018)
DEG improved glycemic control when switched from once-daily BI and maintained glycemic control when switched from twice-daily BI without increasing hypoglycemia.
Keyphrases
  • glycemic control
  • type diabetes
  • blood glucose
  • weight loss
  • insulin resistance
  • physical activity
  • adipose tissue